Pairing Patients with Experimental Cancer Treatment Programs at NCI
NCT00001823 · RecruitingThis study looks at how to evaluate patients who might join experimental cancer treatment programs at the National Cancer Institute Surgery Branch. Doctors will screen patients by reviewing tests and scans to see if they qualify for these special programs. Patients must be 18 or older and suspected of having cancer. The main goal is to find suitable candidates for ongoing research.
Locations and contact
This trial is running at 1 location. It is currently recruiting.
- National Institutes of Health Clinical CenterBethesda, MarylandRecruiting
Who can join
This trial is open to men and women who are at least 18 years old. They should be suspected of having cancer or have a confirmed cancer diagnosis. Participants must be able to understand and sign a consent form. Women who are pregnant or planning to become pregnant cannot join due to possible risks from some tests. The trial team will confirm who qualifies.
What happens during the trial
Participants will undergo various tests and evaluations to see if they can take part in NCI-SB treatment programs. Everyone will be part of a group that includes patients suspected of having cancer. Doctors will assess their eligibility based on the results of these tests over a long period of time.
The trial team
The National Cancer Institute sponsors this trial. The lead doctor is Dr. Steven A. Rosenberg from the National Cancer Institute. They are supported by the National Institutes of Health Clinical Center.
Important dates
The trial started on July 11, 1999, and is currently recruiting new participants. It is expected to continue until June 11, 2026.
Additional information
The trial's ID number is NCT00001823. It is not focused on a specific drug or device. The trial hopes to include up to 7,000 patients in total.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →